ECSP034570A - FORMULATION OF AN INHALATION SOLUTION WITH A TIOTROPIO SALT - Google Patents

FORMULATION OF AN INHALATION SOLUTION WITH A TIOTROPIO SALT

Info

Publication number
ECSP034570A
ECSP034570A EC2003004570A ECSP034570A ECSP034570A EC SP034570 A ECSP034570 A EC SP034570A EC 2003004570 A EC2003004570 A EC 2003004570A EC SP034570 A ECSP034570 A EC SP034570A EC SP034570 A ECSP034570 A EC SP034570A
Authority
EC
Ecuador
Prior art keywords
formulation
tiotropio
salt
inhalation solution
water
Prior art date
Application number
EC2003004570A
Other languages
Spanish (es)
Inventor
Christel Schmelzer
Humke Barbara Niklaus
Petra Barth
Karin Drechsel
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP034570(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP034570A publication Critical patent/ECSP034570A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una formulación para inhalación exenta de gases propelentes de bromuro de tiotropio o monohidrato de bromuro de tiotropio, disuelto en agua o en una mezcla de agua y etanol, así como a los aerosoles inhalables exentos de gases propelentes resultantes de ella.The present invention relates to a formulation for inhalation free of propellant gases of tiotropium bromide or tiotropium bromide monohydrate, dissolved in water or in a mixture of water and ethanol, as well as inhalable aerosols free of propellant gases resulting therefrom. .

EC2003004570A 2000-10-31 2003-04-28 FORMULATION OF AN INHALATION SOLUTION WITH A TIOTROPIO SALT ECSP034570A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10054042 2000-10-31

Publications (1)

Publication Number Publication Date
ECSP034570A true ECSP034570A (en) 2003-06-25

Family

ID=7661727

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004570A ECSP034570A (en) 2000-10-31 2003-04-28 FORMULATION OF AN INHALATION SOLUTION WITH A TIOTROPIO SALT

Country Status (32)

Country Link
EP (1) EP1335729A2 (en)
JP (1) JP4559703B2 (en)
KR (1) KR100983208B1 (en)
CN (1) CN1237970C (en)
AR (1) AR038765A1 (en)
AU (2) AU2002221741B2 (en)
BG (1) BG66425B1 (en)
BR (1) BR0115016A (en)
CA (1) CA2427583C (en)
CZ (1) CZ305033B6 (en)
DE (1) DE10152369A1 (en)
EA (1) EA009068B1 (en)
EC (1) ECSP034570A (en)
EE (1) EE05343B1 (en)
HR (1) HRP20030337A2 (en)
HU (1) HUP0301377A3 (en)
IL (2) IL155676A0 (en)
ME (1) ME00242B (en)
MX (1) MXPA03003750A (en)
MY (1) MY132777A (en)
NO (1) NO332524B1 (en)
NZ (1) NZ526024A (en)
PE (1) PE20020518A1 (en)
PL (1) PL361001A1 (en)
SA (1) SA01220503B1 (en)
SK (1) SK288031B6 (en)
TW (1) TWI296934B (en)
UA (1) UA76435C2 (en)
UY (1) UY26991A1 (en)
WO (1) WO2002036591A2 (en)
YU (1) YU33103A (en)
ZA (1) ZA200303045B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083800A2 (en) 2000-04-28 2001-11-08 Kosan Biosciences, Inc. Heterologous production of polyketides
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2544611A1 (en) * 2003-10-09 2005-04-21 Inverseon, Inc. Method of treating airway diseases with beta-adrenergic inverse agonists
SE0303269L (en) * 2003-12-03 2005-06-04 Microdrug Ag Medical product
SI1863476T1 (en) * 2005-03-16 2016-05-31 Meda Pharma Gmbh & Co. Kg The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
AU2007267523B2 (en) * 2006-05-26 2012-02-09 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
CN100446770C (en) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 Peclomethasone Propionate Water Spray
TR200907237A2 (en) * 2009-09-23 2011-04-21 B�Lg�� Mahmut Tiotropium dry powder combination
CN111936124A (en) * 2018-07-26 2020-11-13 四川海思科制药有限公司 Aerosol pharmaceutical composition containing glycopyrronium salt and indacaterol salt, and preparation method and application thereof
CN116196298A (en) * 2018-07-26 2023-06-02 四川海思科制药有限公司 Aerosol pharmaceutical composition containing glycopyrronium salt and preparation method and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4203306A1 (en) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh ASTHMA OR PULMONAL AEROSOL PREPARATIONS WITH LECITHIN
BR9609307B1 (en) * 1995-06-27 2010-03-09 pharmaceutical preparation for the production of lung-propellant-free inhaled aerosols as well as aerosol comprising the same.
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
CA2256721A1 (en) * 1996-06-04 1997-12-11 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
DE19653969A1 (en) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg New aqueous pharmaceutical preparation for the production of propellant-free aerosols
JPH10298107A (en) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd Pharmaceutical composition
ATE234604T1 (en) * 1998-08-04 2003-04-15 Jago Res Ag MEDICAL AEROSOL FORMULATIONS
DE19847968A1 (en) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit.

Also Published As

Publication number Publication date
AU2174102A (en) 2002-05-15
CN1237970C (en) 2006-01-25
NO20031914D0 (en) 2003-04-29
UY26991A1 (en) 2002-06-20
EA009068B1 (en) 2007-10-26
SK288031B6 (en) 2012-12-03
YU33103A (en) 2006-05-25
JP4559703B2 (en) 2010-10-13
EE200300202A (en) 2003-10-15
MY132777A (en) 2007-10-31
CA2427583A1 (en) 2002-05-10
IL155676A0 (en) 2003-11-23
EA200300483A1 (en) 2003-12-25
AR038765A1 (en) 2005-01-26
JP2004523482A (en) 2004-08-05
WO2002036591A2 (en) 2002-05-10
CZ20031487A3 (en) 2003-09-17
HRP20030337A2 (en) 2005-04-30
SK5262003A3 (en) 2003-10-07
ZA200303045B (en) 2004-04-22
PE20020518A1 (en) 2002-07-12
HUP0301377A2 (en) 2003-10-28
MEP40708A (en) 2011-02-10
BR0115016A (en) 2005-05-03
AU2002221741B2 (en) 2007-04-05
NO20031914L (en) 2003-06-23
ME00242B (en) 2011-05-10
TWI296934B (en) 2008-05-21
BG66425B1 (en) 2014-04-30
KR20040010552A (en) 2004-01-31
IL155676A (en) 2012-05-31
EP1335729A2 (en) 2003-08-20
DE10152369A1 (en) 2002-05-08
MXPA03003750A (en) 2004-10-15
WO2002036591A3 (en) 2002-07-25
NO332524B1 (en) 2012-10-08
NZ526024A (en) 2005-10-28
CZ305033B6 (en) 2015-04-08
SA01220503B1 (en) 2007-03-10
BG107726A (en) 2004-11-30
CA2427583C (en) 2008-02-12
KR100983208B1 (en) 2010-09-20
CN1473044A (en) 2004-02-04
PL361001A1 (en) 2004-09-20
EE05343B1 (en) 2010-10-15
HK1060569A1 (en) 2004-08-13
UA76435C2 (en) 2006-08-15
HUP0301377A3 (en) 2005-12-28

Similar Documents

Publication Publication Date Title
CO5640070A2 (en) FORMULATION FOR AN INHALER WITH DOSE MEASUREMENT THAT USES HYDROFLUOROALCANS AS PROPULSORS
DE60308997D1 (en) FORMULATIONS FOR INHALATION
CU23260B7 (en) MOXIFLOXACINE PHARMACEUTICAL PREPARATION
HRP20030276B1 (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
UY30440A1 (en) NEW COMPOUNDS
EA200300503A1 (en) NEW MEDICINAL COMPOSITIONS BASED ON SALTS OF TIOTROPY AND SALTS OF SALMETEROL
ECSP045221A (en) SALTS OF VALSARTAN
CY1107825T1 (en) INHIBITED SOLUTION TYPE SOLUTIONS
UY26991A1 (en) FORMULATION IN INHALABLE SOLUTION WITH A TIOTROPIO SALT
SV2006002274A (en) DERIVATIVES OF 2-AMIDO-4-PHENYLTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
AR029795A1 (en) ACID DERIVATIVES 1,2,3,4-TETRAHYDROQUINOLIN-2-CARBOXILICO REPLACED, PROCEDURES FOR THEIR PREPARATION, ITS USE FOR THE PREPARATION OF MEDICINES AND MEDICINES CONTAINING THESE COMPOUNDS
EA200401303A1 (en) MEDICINES CONTAINING STEROIDS AND NEW ANTICHOLINERGIC MEANS
UY27754A1 (en) AEROSOL FORMULATION FOR INHALATION CONTAINING A TIOTROPIO SALT.
UY27324A1 (en) NEW NAPSILATE SALTS I
TR200600987T1 (en) 7-carboxymethyloxy-3 ', 4', 5-trimethoxy flavone-monohydrate, preparation method and its use
AR063597A1 (en) NEW SALT
BR0107483A (en) Process for the preparation of a compound
HN2001000021A (en) NEW DERIVATIVES OF AMETAS HETEROCICLICAS
BRPI0300660B8 (en) method to quantify mitochondrial release of cytochrome c and kit to detect mitochondrial release of cytochrome c
CO4750644A1 (en) NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS